We are live on
!
Find out more
FAF
Fjarde Ap-fonden Portfolio holdings
AUM
$20.9B
1-Year Est. Return
36.93%
This Fund
S&P 500
This Quarter
Est. Return
+1.75%
1 Year Est. Return
+36.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.8B
AUM Growth
-$76.2M
(-0.7%)
Cap. Flow
-$178M
Cap. Flow
% of AUM
-1.64%
Top 10 Holdings %
Top 10 Hldgs %
28.27%
Holding
568
New
2
Increased
152
Reduced
375
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$113M |
| 2 |
Amazon
AMZN
|
+$16.9M |
| 3 |
Snowflake
SNOW
|
+$15.1M |
| 4 |
Palantir
PLTR
|
+$7.78M |
| 5 |
Analog Devices
ADI
|
+$7.35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$22.8M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$22.7M |
| 3 |
Microsoft
MSFT
|
+$16.2M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$12.5M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.75% |
| 2 | Financials | 14.45% |
| 3 | Healthcare | 13.61% |
| 4 | Consumer Discretionary | 11.84% |
| 5 | Communication Services | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
FMC
FMC
$1.33B
| $5.82M | 0.05% |
63,537
-700
| -1% | -$69.1K |
|
352
LyondellBasell Industries
LYB
$19.2B
| $5.8M | 0.05% |
61,796
-16,600
| -21% | -$1.63M |
|
353
Burlington
BURL
$23.2B
| $5.79M | 0.05% |
20,421
-500
| -2% | -$160K |
|
354
Revvity
RVTY
$12.8B
| $5.74M | 0.05% |
33,100
-3,500
| -10% | -$617K |
|
355
Kraft Heinz
KHC
$30B
| $5.73M | 0.05% |
155,614
-18,700
| -11% | -$704K |
|
356
Ball Corp
BALL
$16.8B
| $5.68M | 0.05% |
63,085
-9,269
| -13% | -$822K |
|
|
Y
357
DELISTED
Alleghany Corp
Y
| $5.66M | 0.05% |
9,064
+43
| +0.5% | +$28.4K |
|
358
Royal Caribbean
RCL
$85.6B
| $5.65M | 0.05% |
63,502
-3,300
| -5% | -$267K |
|
359
IDEX
IEX
$17.3B
| $5.64M | 0.05% |
27,246
-5,000
| -16% | -$1.11M |
|
360
Nasdaq
NDAQ
$52.9B
| $5.63M | 0.05% |
87,582
+300
| +0.3% | +$18.9K |
|
361
Ventas
VTR
$47.9B
| $5.63M | 0.05% |
101,909
-7,200
| -7% | -$413K |
|
362
Realty Income
O
$59.1B
| $5.61M | 0.05% |
89,277
+929
| +1% | +$62.7K |
|
|
VMW
363
DELISTED
VMware, Inc
VMW
| $5.6M | 0.05% |
37,630
-200
| -0.5% | -$30.3K |
|
364
Camden Property Trust
CPT
$11.1B
| $5.58M | 0.05% |
37,842
-4,900
| -11% | -$718K |
|
365
C.H. Robinson
CHRW
$17.5B
| $5.54M | 0.05% |
63,695
+7,500
| +13% | +$678K |
|
366
Robert Half
RHI
$4.37B
| $5.53M | 0.05% |
55,159
-300
| -0.5% | -$29.4K |
|
367
Equity Lifestyle Properties
ELS
$12.6B
| $5.53M | 0.05% |
70,788
-1,500
| -2% | -$123K |
|
368
Invitation Homes
INVH
$18B
| $5.5M | 0.05% |
143,483
+3,000
| +2% | +$120K |
|
369
Boston Properties
BXP
$11.1B
| $5.48M | 0.05% |
50,588
-1,700
| -3% | -$194K |
|
370
Viatris
VTRS
$19.1B
| $5.46M | 0.05% |
403,190
+20,400
| +5% | +$289K |
|
371
Quest Diagnostics
DGX
$26.3B
| $5.45M | 0.05% |
37,515
-4,200
| -10% | -$615K |
|
372
Clorox
CLX
$12.7B
| $5.44M | 0.05% |
32,860
-5,500
| -14% | -$947K |
|
373
DoorDash
DASH
$93.7B
| $5.42M | 0.05% |
+26,300
| New | +$5.03M |
|
|
EXAS
374
DELISTED
Exact Sciences
EXAS
| $5.41M | 0.05% |
56,700
| – | – |
|
|
ZEN
375
DELISTED
ZENDESK INC
ZEN
| $5.4M | 0.05% |
46,400
-1,000
| -2% | -$129K |
|
Similar funds
MMH
VARA
SC
CB
MIC
GT
Fjarde Ap-fonden's Q3 2021 Portfolio in Review
As of Q3 2021, Fjarde Ap-fonden held 568 positions worth $10.8B, down 0.7% from $10.9B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 1.9%. Fjarde Ap-fonden opened 2 new positions and exited 9, leaving the 568-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Fjarde Ap-fonden's largest Q3 2021 buy was DoorDash: 26,300 shares worth $5.42M.
- Fjarde Ap-fonden added most to iShares MSCI USA Value Factor ETF in Q3 2021, an estimated $113M increase.
- Fjarde Ap-fonden's biggest Q3 2021 reduction was Apple, cutting an estimated $22.8M.
- Fjarde Ap-fonden fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $12.5M.
- Fjarde Ap-fonden's ten largest holdings make up 28% of its $10.8B portfolio in Q3 2021.
- Fjarde Ap-fonden opened 2 new positions and closed 9 in Q3 2021.
- Fjarde Ap-fonden's portfolio value fell 0.7% quarter-over-quarter to $10.8B.
Based on Fjarde Ap-fonden's 13F filing for Q3 2021, filed 15 Nov 2021.